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Abstract
Purpose The purpose of the study was to validate the AQoL-8D questionnaire in the adult population of patients referred 
to an otolaryngology clinic.
Methods AQoL-8D was translated into Polish. 463 patients (age18–80 years) with otolaryngological conditions were 
assessed with the AQoL-8D, SF-6D, and SWLS questionnaires. We investigated the item content-relevance, factor structure 
by means of Confirmatory Factor Analysis, corrected item-total correlations, Cronbach’s alpha, Pearson correlation of the 
AQoL-8D scores with results from SF-6D and from the SWLS questionnaires. Finally, ANOVA was used to test the AQoL-
8D ability to group the HRQoL of patients in terms of their otolaryngological management type.
Results The median score of item content-relevance was 5.0 for all AQoL-8D items. Confirmatory Factor Analysis revealed 
the following fit indices: Comparative Fit Index = 0.81; Tucker–Lewis Index = 0.80; and Root Mean Square Error of Approxi-
mation = 0.07. Cronbach’s alpha for AQoL-8D dimensions ranged from 0.48 to 0.79. Mean item-total correlations over all 
dimensions, super dimensions, and the instrument overall were higher than 0.3. There was a significant Pearson correlation 
between the results obtained with AQoL-8D and SF-6D (r = 0.68), and with AQoL-8D and SWLS (r = 0.43). A one-way 
ANOVA showed a significant effect of management type on HRQoL as measured by AQoL-8D [F(4,458) = 6.12, p < 0.001]
Conclusion AQoL-8D provides valid and reliable measures of HRQoL in patients undergoing otolaryngological treatment. 
Because it is a generic questionnaire, it is possible to make general comparisons of otolaryngology outcomes with those 
from other subspecialties.
Keywords Health-related quality of life · Validation · Patient-reported outcome measures · Otolaryngology · Hearing 
impairment
Introduction
To make comparisons between one treatment or health 
problem with another, it is recommended in principle to 
use standardised Health-Related Quality of Life (HRQoL) 
questionnaires which are validated, generic (non-disease-
specific), and can provide a single outcome measure—a Util-
ity Index (UI) [1, 2]. In comparison to other subspecialties, 
there is a relative lack of such utility analyses in otolaryn-
gology [3]. So far, HRQoL has been evaluated mainly in 
the specific domains of hearing aids, cochlear implants, and 
head and neck cancer using a wide range of instruments, 
mostly disease-specific [4].
Evaluation of the general population of patients referred 
to otolaryngology clinics using a generic HRQoL question-
naire would be particularly useful, as the outcomes thus 
obtained would allow broader comparisons of otolaryngol-
ogy with other subspecialties, especially since the majority 
of otolaryngology problems are neither life-threatening nor 
require surgery and so do not allow comparisons in terms of 
mortality rate or surgical success rate.
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The only study to date on HRQoL in a population referred 
to an otolaryngology clinic was performed by Swan et al. 
[5] on a group of 9005 adult patients. The Health Utilities 
Index mark 3 (HUI-3) instrument was applied before and 
after treatment. The authors found that patients treated sur-
gically or with hearing aids reported a small but signifi-
cant improvement in their HRQoL, while patients treated in 
other ways reported no significant improvement [5]. These 
results suggest that HUI-3 is probably not sensitive enough 
to measure changes in HRQoL in all groups of otolaryngol-
ogy patients.
From the published findings it is not clear what instru-
ment could capture HRQoL for a population undergoing 
an otolaryngological intervention [5–7]. Nevertheless, the 
choice of HRQoL instrument is important and needs to 
be made according to the target population. Methods for 
HRQoL measurement vary not only in terms of the scaling 
technique and the model used to derive the scoring formula, 
but also in terms of the type and scope of the questions, the 
number of health states measured, and the number of dimen-
sions covered [8, 9]. Because there are no single generally 
agreed-upon definition of HRQoL and no gold standard for 
HRQoL measurements, the general recommendation is to 
use an instrument that covers all the dimensions considered 
important for the study population [1, 10].
Moreover, since each instrument differs in its sensitiv-
ity to particular health dimensions, the question arises as 
to what instrument would provide valid measures for the 
population of patients referred to otolaryngology, taking into 
account diversity of this population in terms of age, type 
of intervention, and health status. In trying to answer this 
question, it is important to realise that many otolaryngol-
ogy problems (e.g. hearing loss, vertigo, tinnitus) are often 
associated with long-lasting disabilities which usually have 
severe psycho-social consequences [11–14]. Therefore, 
a HRQoL instrument suitable for evaluating otolaryngol-
ogy patients needs to place a strong emphasis on items in 
the psycho-social domain. An analysis of the descriptive 
systems of most common instruments, done by Richardson 
et al. [15], showed that each instrument displayed significant 
differences in the proportion of items related to the physi-
cal and psycho-social domains. In their analysis authors 
compared five generic health utility measures: EuroQol-5 
Dimension (EQ-5D), Health Utilities Index mark 3 (HUI-3), 
15-dimensional measure of HRQoL (15D), Short-Form Six-
Dimension (SF-6D), and Assessment of Quality of Life-8 
Dimensions (AQoL-8D). AQoL-8D is the instrument which 
has items related to hearing and with the largest proportion 
of items in the psycho-social domain, therefore, is mostly 
suitable to capture domains important for otolaryngology.
The AQoL-8D consists of 35 items covering 8 dimen-
sions: Independent Living, Pain, Senses, Mental Health, 
Happiness, Coping, Relationships, and Self-worth [16, 17]. 
To ensure its content validity (the extent to which an instru-
ment covers all aspects of the intended construct, that is, 
HRQoL), AQoL-8D was derived using psychometric meth-
ods. For each dimension, each health state has been evalu-
ated using both a visual analogue sale (VAS) and a time 
trade-off (TTO) technique, which are common methods used 
to estimate the utility of the health state. To derive a single 
valid utility index (UI), a two-stage multiplicative–econo-
metric scaling procedure was used [18].
The general aim of this research is to obtain valid evi-
dence of the AQoL-8D questionnaire in a population of adult 
patients referred to our otolaryngology clinic.
Material and methods
Participants
All adult patients who were referred during 3 consecutive 
months for a consultation with the Institute of Physiology 
and Pathology of Hearing (IPPH) in Warsaw were asked to 
participate in the study. A total of 463 patients consented 
to take part.
Study design
Between 01.08.2016 and 31.10.2016 patients were evalu-
ated with a translated Polish version of the AQoL-8D ques-
tionnaire; a Polish adapted version of the SF-36 (a HRQoL 
assessment questionnaire) [19–21]; an adapted version of the 
SWLS (Satisfaction with Life Scale, an assessment of sub-
jective well-being) [22, 23]; and asked general survey ques-
tions on socio-demographic variables. All scales and soci-
odemographic questions were compiled in a single survey 
questionnaire. Once patients were told about the research 
project’s aims and asked to take part in the study, they filled 
out the consent form and questionnaire. Completed question-
naires were put in a plain envelope to guarantee confidential-
ity. The study was designed and conducted according to the 
Declaration of Helsinki and the study protocol was approved 
by the Institutional Review Board IFPS: KB/06 /2016.
Translation of the AQoL‑8D into Polish
To validate the AQoL-8D in the target population (patients 
referred to otolaryngology clinic), the translation of the 
AQoL-8D into Polish was conducted. A “committee 
approach to translation” design was applied to develop 
the Polish version of the AQoL-8D following the TRAPD 
(Translation, Review, Adjudication, Pretesting, and Docu-
mentation) model [24]. A “committee-approach to transla-
tion” is a three-stage translation method intended to provide 
an appropriate translated version of the questionnaire in the 
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target language considering linguistic, cultural and content 
issues. This design is recommended in different professional 
guidelines, for instance, the International Test Commission 
Guidelines for Translating and Adapting Test [25]. The 
translation team consisted of two translators, a reviewer, and 
an adjudicator. At the first stage of the process, the transla-
tors worked separately, preparing independent translations. 
The reviewer’s task in the team was to review and edit the 
translations of AQoL-8D items, instructions, and rubrics. 
Next, the translation team led by the adjudicator met and 
discussed the two translations item by item until they arrived 
at the draft of the Polish version of the AQoL-8D question-
naire. The adjudicator took care of methodological issues 
through the whole translation process and documented all 
points discussed during the meetings.
To examine the quality of translation, the comparability 
between the original and Polish versions of the AQoL-8D 
questionnaire was investigated by an appraisal by a panel 
of experts. Thirteen experts were asked to rate each item 
by the comparability of the original version and the Polish 
version of the AQoL-8D questionnaire on a numbered scale 
from 1 (no comparability) to 5 (perfect comparability). For 
all AQoL-8D items, the median score of comparability was 
5.0, with the means ranging from 4.3 to 5.0. These results 
show that experts assessed all Polish items in a highly com-
parable way to that of the original version. Moreover, the 
inter-quartile ranges of experts’ ratings were never above 1, 
indicating a high level of agreement among the experts. The 
results of experts’ appraisal demonstrate the high quality of 
AQoL-8D translation into Polish.
Data analysis
The first step in researching the AQoL-8D’s validity in a 
population of patients referred to otolaryngology clinic was 
to examine item content-relevance by an expert appraisal. 
Thirteen experts were recruited from IPPH employees 
working in different departments of the Institute. The group 
consisted of medical doctors (specialists in otolaryngology, 
audiology, and phoniatrics), audiologists, speech-language 
pathologist, and psychologists. Experts were asked to rate 
the relevance of each AQoL-8D item on a numbered scale 
from 1 (highly irrelevant) to 5 (highly relevant). If the rating 
was below 4, they were asked to provide comments explain-
ing why in their opinion the item content is not relevant for 
the target population.
The second validation step was to examine the AQoL-8D 
questionnaire’s internal structure, understood as its factor 
structure and score reliability. Confirmatory Factor Analysis 
(CFA) was performed to examine whether the data fitted the 
hypothesised eight-dimensional model of the original ver-
sion of AQol-8D [26]. The AQoL-8D consists of 35 items 
covering 8 dimensions: Independent Living, Pain, Senses, 
Mental Health, Happiness, Coping, Relationships, and Self-
worth. Three of them (Independent Living, Pain, Senses) are 
related to a physical ‘super-dimension’ and the remaining 
five to a psycho-social ‘super-dimension’ [16, 17].
Calculations were done of standardised factor loadings 
as well as the usual fit indices (CFI, Comparative Fit Index; 
TLI, Tucker–Lewis Index; and RMSEA, Root Mean Square 
Error of Approximation). A Weighted Least Square Mean 
and Variance-adjusted (WLSMV) estimation method was 
applied which considered all AQol-8D items as categorical 
variables. Next the item analysis was done and descriptive 
statistics (mean and standard deviation) calculated. Cor-
rected item-total correlations were assessed to examine the 
discrimination of the AQoL-8D items in all dimensions, in 
the super dimensions, and for the whole instrument. Cron-
bach alpha coefficients were computed to examine the reli-
ability of the AQoL-8D scores.
The third step in obtaining validity evidence for AQoL-
8D was to analyse the Pearson correlations of the UI of 
AQoL-8D with the UI of SF-6D (as calculated from SF-36). 
A strong correlation between those two measures indicates 
that they are both gauging the same construct—HRQoL. In 
addition, the correlation between the AQoL-8D UI and the 
SWLS total score was calculated to examine the relationship 
of AQoL-8D results to a measure of subjective well-being 
(which is a concept similar to HRQoL). The Pearson correla-
tion of the AQoL-8D UI with the SF-36 dimensions was also 
calculated to investigate the hypothesis that psycho-social 
domains were well represented in the AQoL-8D total score.
Finally, the ability of AQoL-8D to differentiate between 
groups of patients classified into different management types 
was examined. One-way ANOVA was used to determine 
whether the AQoL-8D UI and the results of the AQoL-8D 
dimensions and the super dimensions differed significantly 
between management types. Statistical analyses were per-
formed using MPlus version 7.3 and Statistica version 12.0.
Results
Participants
A total of 463 patients aged between 18 and 80 years old 
participated in the study. Their mean age was 47 years old 
(SD 16.2); 201 were men aged between 18 and 76 years 
(mean 47; SD 16.7), and 262 were women, aged 18–80 years 
old (mean 47; SD 15.8). Age and gender of the study group 
are presented in Table 1. Patients were classified into five 
types of otolaryngological management: 13% medical treat-
ment (medication); 22% cochlear implantation (CI); 12% 
hearing aid (HA) or middle ear implant (MEI) provision; 
44% surgery (other than CI and MEI); and 9% given reassur-
ance or advice on self-management (the ‘reassure’ group).
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Item content‑relevance
For all AQoL-8D items, the median score of content-rel-
evance was 5.0, with the means ranging from 4.1 to 5.0. 
The lowest mean experts’ ratings were obtained for items 
related to vision, 4.1 (item 28); mobility, 4.2 (item 15); and 
degree of pain, 4.5 (item 22). These results show that experts 
assessed most AQoL-8D items as highly relevant to meas-
ure HRQoL in patients who are receiving otolaryngological 
treatment. Moreover, the inter-quartile ranges of experts’ 
ratings were zero for all AQoL-8D items except for items 
no. 28, 15, and 22 where the inter-quartile ranges were 2, 1, 
and 2, respectively.
Internal structure
CFA was also used to test the original eight-dimension 
model for the AQoL-8D. The model, together with the 
standardised factor loadings for items, dimensions, and super 
dimensions, is presented in Fig. 1. The values of the fit sta-
tistics were: CFI = 0.85, TLI = 0.84, and RMSEA = 0.07. 
While the values of CFI and TLI were slightly below the 
usual cut-off [27], the RMSEA values were considered good.
Table 2 shows the mean total scores, standard deviations, 
Cronbach’s alpha, and item discriminations for the 8 dimen-
sions, 2 super dimensions, and the whole instrument. Values 
of Cronbach’s alpha for the AQoL-8D dimensions ranged 
from 0.48 (Senses) to 0.79 (Happiness) and exceeded 0.7 for 
the super dimensions and the whole instrument. Mean item-
total correlations for all dimensions, super dimensions, and 
instrument were higher than 0.3. The lowest individual item-
total correlation was 0.19 for item 28 (related to vision).
Relation to other variables
Figure 2a shows that the Pearson correlation between UIs 
calculated from SF-6D and AQoL-8D was strong (r = 0.68) 
and significant (p < 0.01). Figure 2b shows that there was 
a smaller but significant (p < 0.01) correlation between 
AQoL-8D scores and the SWLS instrument (r = 0.43). The 
correlations of AQoL-8D UI with SF-36 dimensions were 
all significant at the level of 0.01 and were as follow: 0.42, 
general health; 0.51, bodily pain; 0.44, physical functioning; 
0.45, role limitation (physical); 0.56, vitality; 0.52, social 
functioning; 0.42, role limitation (emotional); 0.62, mental 
health; 0.59, PCS (Physical Component Summary); 0.68, 
MCS (Mental Component Summary).
A one-way ANOVA showed a significant effect 
of management type on UI measured by AQoL-8D 
[F(4,458) = 6.12, p < 0.001]. Similarly, the significant 
effect of management type on HRQoL measured in the 
Physical super dimension [F(4, 458) = 8.22, p < 0.001] and 
in the Psycho-social super dimension [F(4, 458) = 3.65, 
p = 0.006] was observed. Moreover, a significant effect of 
patient management type on HRQoL was found in five out 
of eight dimensions: Independent Living, F(4,449) = 3.76, 
p = 0.005; Senses, F(4,435) = 18.49, p < 0.001; Happiness, 
F(4,441) = 3.87, p = 0.004; Relationships, F(4,447) = 2.85, 
p = 0.024; and Self-worth, F(4,439) = 3.99, p = 0.003. The 
effect was not observed for Pain [F(4,431) = 1.25, p = 0.291]; 
Mental Health [F(4,434) = 1.97, p = 0.098]; or Coping 
[F(4,450) = 2.27, p = 0.061]. The results of AQoL-8D UI 
obtained in patients assigned to each of the five groups of 
otolaryngological management, including post hoc compari-
sons, are shown in Table 3.
Discussion
To reliably interpret any HRQoL measure, it must have 
strong validity, and this property is currently considered 
the most important metric [28–30]. Following the current 
understanding of validity, "validation" is considered to be 
the ongoing endeavour in which different strands of valid-
ity evidence are gathered, summarised, and integrated to 
support the intended interpretation of the selected HRQoL 
measure [31]. Among the sources of validity evidence, 
i.e., validation methods, two approaches are particularly 
relevant for HRQoL measures: “internal structure” and 
“relation to other variables” [32]. The rationale behind the 
focus on the internal structure of an instrument is to test 
whether the data fit a hypothetical measurement model of 
Table 1  Age and gender of the 
study group
Age range Male Female Total
N % N % N %
18–20 14 7.0 9 3.4 23 5.0
21–30 34 16.9 48 18.3 82 17.7
31–40 21 10.4 37 14.1 58 12.5
41–50 43 21.4 47 17.9 90 19.4
51–60 38 18.9 63 24.0 101 21.8
61–70 38 18.9 41 15.6 79 17.1
71–80 13 6.5 17 6.5 30 6.5
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how items and dimensions account for responses. “Relation 
to other variables” can be explored in three ways: the extent 
to which a measure of the intended concept correlates with 
another widely accepted measure of the same concept (i.e. 
traditional “convergent validity”); correlation with other 
measures of theoretically related constructs; and by demon-
strating when a questionnaire can discriminate between two 
groups known to differ on the variable of interest. All these 
strands of validity evidence can support the interpretation 
of an HRQoL measure in a target population.
The assessment of item content-relevance shows that 
experts regarded almost all of the AQoL-8D items as 
highly relevant for measuring HRQoL in patients receiv-
ing otolaryngological treatment. The results also indi-
cate a high level of agreement among the experts. The 






























































































Fig. 1  Structure of AQoL-8D and the factor loadings on super dimensions, dimensions, and individual items
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items had a content-relevance which raised doubts among 
experts about their importance. Only item 28 relating to 
vision (Senses dimension), item 15 with a reference to 
mobility (Independent Living dimension), and item 22 
considering the degree of pain (Pain dimension) were 
rated less relevant than the rest of the items. Moreover, for 
Table 2  Descriptive statistics 
of AQoL-8D scores; 
discrimination capacity of the 
items; and scores reliability 
for the dimensions, super 




Discrimination capacity of items Scores reliability









Independent living 0.89 0.11 0.45 0.34 0.50 0.64
Pain 0.78 0.21 0.62 0.59 0.65 0.78
Senses 0.74 0.16 0.31 0.19 0.46 0.48
Mental health 0.58 0.11 0.48 0.35 0.62 0.77
Happiness 0.76 0.13 0.61 0.47 0.69 0.79
Coping 0.80 0.13 0.37 0.35 0.40 0.56
Relationships 0.73 0.14 0.45 0.31 0.59 0.74
Self-worth 0.81 0.13 0.49 0.45 0.53 0.67
Super dimensions
Physical 0.65 0.18 0.45 0.34 0.55 0.77
Psycho-social 0.38 0.16 0.54 0.29 0.70 0.92
Instrument


































AQoL-8D Ulity Index (b)(a)
Fig. 2  Scatterplots of a SF 6D vs AQoL-8D utility scores; b SWLS total scores vs AQoL-8D utility scores. Solid lines are regressions; dashed 
lines are theoretically ideal 1:1 relationships
Table 3  ANOVA comparisons 
of AQoL-8D UI results for 
five types of otolaryngological 
management
Management type N Mean SD Post hoc comparisons
Medication CI HA or MEI Surgery
Medication 61 0.74 0.16
CI 103 0.64 0.17 < 0.001
HA or MEI 54 0.62 0.17 < 0.001 0.484
Surgery 204 0.70 0.16 0.081 0.005 0.003
Reassure 41 0.71 0.15 0.418 0.022 0.009 0.603
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those same items the inter-quartile ranges of the experts 
ratings were the highest, showing that there were appre-
ciable differences in the experts’ opinions. For the tar-
get population—patients referred for otolaryngological 
treatment—pain and mobility problems are not frequent, 
although some diseases (e.g., otitis media) can cause pain 
and some (e.g., vertigo) can result in mobility problems. 
The question about vision seemed to be the least relevant 
for the assessed population.
Results of the CFA allow us to be confident that the data 
obtained from the patients responding to the Polish version 
of AQoL-8D can be accounted for by the same model as the 
original version. The results of the CFA of the original ver-
sion done by Richardson et al. [18] revealed almost identical 
factor loadings as the ones of the Polish version presented in 
Fig. 1. Some values of the fit statistics were below the usual 
cut-offs [27]. To interpret these results, differences between 
the validation study of the original AQoL-8D and the valida-
tion study of the Polish version should be taken into account. 
The validation of the original AQoL-8D was performed in 
a sample of the general population, while the Polish version 
was validated in a population of patients undergoing otolar-
yngological treatment. In addition, there are also differences 
in administration modes used in both validation studies. It 
seems that the different CFA results might be explained by 
sample dependency, the difference in administration mode, 
translation effects, and the special characteristics of patients 
undergoing otolaryngological treatment.
Values of Cronbach’s alpha above 0.7 are generally 
considered adequate [33]. In the current study, the highest 
values of Cronbach’s alpha were found for AQoL-8D and 
for the Psycho-Social super dimension (above 0.9). Values 
below 0.7 were obtained for four dimensions: Independent 
Living, Senses, Coping, and Self-worth. This is in line with 
the finding that Cronbach’s alpha depends on the length 
of the test [34, 35]. In the case of the AQoL-8D question-
naire, both the instrument itself and the Psycho-Social super 
dimension comprise a large number of items (35 and 25, 
respectively). In contrast, dimensions with the lowest val-
ues of Cronbach’s alpha consist of just 3 or 4 items for each 
dimension. A value below 0.7 for the Senses dimension has 
also been reported by the authors of AQoL-8D [18, 36]; they 
hypothesised that this complex dimension consists of too 
few items to be a good stand-alone scale.
Mean item-total correlations for all dimensions were 
higher than 0.30, indicating that the items had a high dis-
crimination capacity. The lowest item-total correlation 
(0.19) was obtained for item number 28 relating to vision 
(in the Senses dimension). This is not surprising, since the 
HRQoL was assessed in a group of patients receiving otolar-
yngological treatment, not the general population. Moreover, 
the vision question received the lowest rating in terms of 
relevance.
The strong correlation between the AQoL-8D UI and 
the SF 6D UI confirms that both instruments measure the 
same construct (that is, HRQoL). The value of our correla-
tion coefficient (r = 0.68) is in the same range as reported 
by other studies (0.55–0.81) which evaluated HRQoL in 
both healthy subjects and in patients with different health 
conditions (arthritis, asthma, cancer, chronic obstructive 
pulmonary disease, depression, diabetes, chronic heart dis-
ease, stroke, hearing problems) [37–41]. The correlation 
between the AQoL-8D UI and the SWLS total score was 
lower (by 0.25) than between AQoL-8D and SF-6D. This 
weaker correlation is not surprising since those instruments 
are not measuring the same construct as examined here but a 
closely related concept instead (HRQoL in the first case and 
subjective well-being in the second). Lower correlation coef-
ficients between AQoL-8D and SWLS (0.44–0.73) were also 
reported in a series of reports by Richardson et al. [37–40].
Analysing the relation between AQoL-8D UI and SF 6D 
UI (Fig. 2a) it is clear that AQoL-8D provided a greater 
range of scores (0.21–0.99) in the tested population com-
pared to SF-6D (0.42–1.00). The utility scores achieved by 
SF-6D are compressed into the upper range of the utility 
scale. That is, a change in scores reported by SF-6D cor-
responds to a much larger change in scores in AQoL-8D. 
The outcome is that the regression line has a shallower 
slope compared to the theoretically ideal relationship. This 
indicates that AQoL-8D has a greater capacity to detect 
changes in the HRQoL of the target population compared to 
the SF-6D instrument. Moreover, AQoL-8D has the highest 
correlation with the Mental Health dimension and with the 
Mental Component Summary of SF-36. This is in line with 
findings reported by Richardson et al. [36] and confirms the 
substantial effect of the psycho-social component of AQoL-
8D in HRQoL assessments.
We measured the HRQoL of a broad spectrum of 
patients referred to our otolaryngology clinic. To enlarge 
the evidence base for validity, relations to other variables 
were examined—the group differences in AQoL-8D score 
between management types. This approach also called 
the “known group method”, is a common way to enlarge 
the scope of validity evidence [42]. After classifying our 
patients into five types of otolaryngological management, 
we found that the AQoL-8D scores differed substantially 
across management type (from 0.62 for those provided with 
a hearing aid to 0.74 for those treated with medication). The 
mean value for the comparison population was 0.80, indicat-
ing that the overall HRQoL of our otolaryngological sample 
was substantially poorer [43].
AQoL-8D is based on the WHO definition of health, 
with a primary emphasis upon handicap (activity limita-
tion and participation restriction) rather than just impair-
ment. According to WHO, impairment is defined as a 
problem in body function or structure, such as a significant 
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deviation or loss [44]. Activity is the execution of a task or 
action by an individual, whereas participation is involve-
ment in a life situation. We surmise that management types 
such as surgery and medication (which cure illness by sub-
stantially reducing impairment and restore normal activity 
and participation) result in better HRQoL that the man-
agement types (hearing aids and cochlear implants) used 
primarily in for chronic conditions such as sensorineural 
hearing loss (SNHL)—which are strongly associated with 
handicap (activity limitation and participation restriction). 
In SNHL, an impairment (cochlear damage) has direct and 
immediate effects on most aspects of auditory function, 
including sensitivity, resolution, discrimination ability, 
and resistance to noise. Any deficit of function, which can 
only be partially overcome by a prosthetic device such as a 
hearing aid or cochlear implant, produces a deficit in activ-
ity, especially speech perception and oral communication. 
In turn, reduced activity seriously impacts participation.
As speculated, the AQoL-8D utility index was signifi-
cantly higher in the group of patients who had surgery or 
were treated with medication than in the group of hear-
ing aid or cochlear implant users. A similar pattern was 
also seen in AQoL-8D scores both in the Physical and 
Psycho-Social super dimensions. We have, therefore, dem-
onstrated that AQoL-8D will return different scores for 
patient groups that vary in terms of management type.
Since HRQoL instruments produce different utility 
indexes [15], our results can only be applied with cau-
tion to the HUI-3 scores derived from patients having 
different otolaryngological managements. Swan et al. [5] 
have reported the following HUI-3 scores: 0.54 for those 
provided with hearing aids; 0.67 for those managed with 
medication; and 0.73 for those managed with surgery. The 
AQoL-8D scores for the same groups of patients strati-
fied according to management type are 0.62, 0.74, and 
0.70, respectively. That is, the results from both utility 
instruments are similar. Moreover, they show that the low-
est HRQoL are for hearing aid users, which reflects the 
remaining handicap component (activity limitation and 
participation restriction) in that particular group. It would 
seem that the reason for this is that distortion, over and 
above simple attenuation, which accompanies SNHL is 
a prime factor in creating the difficulties such listeners 
experience in understanding speech (particularly in back-
ground noise). It follows that the amplification provided 
by hearing aids has only a limited capacity to return those 
abilities to normal [45].
The finding that the AQoL-8D is sensitive enough to 
demonstrate the negative impact of otolaryngology problems 
on quality of life is encouraging. As it is common practice to 
provide ‘population norms’: estimates of the average scores 
for different age-gender cohorts, future studies are needed 
with a special focus on elderly patients.
Conclusions
Our results demonstrate that the AQoL-8D items are highly 
appropriate for measuring HRQoL in patients referred 
to otolaryngology clinics. They show that the patients’ 
responses to the items were highly consistent, and revealed 
that AQoL-8D can reliably distinguish various levels of 
HRQoL. We, therefore, conclude that AQoL-8D is a valid 
and reliable tool for assessing Health-Related Quality of Life 
in patients undergoing otolaryngological treatment.
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